Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Serine phosphorylation of insulin receptor substrate-1 (IRS-1) inhibits insulin signal transduction in a variety of cell backgrounds, which might contribute to peripheral insulin resistance. However, because of the large number of potential phosphorylation sites, the mechanism of inhibition has been difficult to determine. One serine residue located near the phosphotyrosine-binding (PTB) domain in IRS-1 (Ser(307) in rat IRS-1 or Ser(312) in human IRS-1) is phosphorylated via several mechanisms, including insulin-stimulated kinases or stress-activated kinases like JNK1. During a yeast tri-hybrid assay, phosphorylation of Ser(307) by JNK1 disrupted the interaction between the catalytic domain of the insulin receptor and the PTB domain of IRS-1. In 32D myeloid progenitor cells, phosphorylation of Ser(307) inhibited insulin stimulation of the phosphatidylinositol 3-kinase and MAPK cascades. These results suggest that inhibition of PTB domain function in IRS-1 by phosphorylation of Ser(307) (Ser(312) in human IRS-1) might be a general mechanism to regulate insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, phosphorylation of these serine residues impedes the normal association of IRS-1 with the insulin receptor, thereby impairing downstream propagation of insulin signaling (16,19).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationStructure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Self-citationAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Self-citationKuan, C.-Y., Yang, D. D., Roy, D. R. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1999) · Neuron · doi:10.1016/s0896-6273(00)80727-8 · Cited by 894
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Self-citationA Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
Research works printed but not linked: 6
- Maezono, 1998, Diabetes, 47, 333A
- Carboni, 1995, Oncogene, 10, 1905
- Myers, 1994, Mol. Cell. Biol., 14, 3577
- Delahaye, 1998, Endocrinology, 139, 4911, 10.1210/endo.139.12.6379 · DOI · Paper page
- O'Neill, 1994, Mol. Cell. Biol., 14, 6433
- Chin, 1994, Mol. Endocrinol., 8, 51
Cited by
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Self-citationInflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
“This phosphorylation reduces both tyrosine phosphorylation of IRS-1 in response to insulin and the ability of IRS-1 to associate with the insulin receptor and thereby inhibits downstream signal - ing and insulin action (35, 37, 38).”
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
“One area of intense study has been the regulation of stress-activated signaling pathways including nuclear factor-B (NF-B), p38 MAPK, NH 2 -terminal Jun kinases/stress-activated protein kinases (JNK/SAPK), advanced glycosylation end-products (AGE)/ receptor for AGE (RAGE), and protein kinase C (PKC).”
BackgroundFrom endoplasmic-reticulum stress to the inflammatory response
Zhang, K., & Kaufman, R. J. (2008) · Nature · doi:10.1038/nature07203 · Cited by 2,010
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
Self-citationAdipose tissue dysfunction as determinant of obesity-associated metabolic complications
Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G. A., Beguinot, F., & Miele, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092358 · Cited by 1,575
“Abbreviations MDPI Multidisciplinary Digital Publishing Institute T2D type 2 diabetes WAT white adipose tissue SAT subcutaneous adipose tissue NAFLD non-alcoholic fatty liver disease BMI body mass index VAT visceral adipose tissue CVD cardiovascular disease MONW metabolically obese normal-weight GLUT4 glucose transpor…”
BackgroundInfluentialMammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
Kyriakis, J. M., & Avruch, J. (2012) · Physiological Reviews · doi:10.1152/physrev.00028.2011 · Cited by 1,466
“The recognition of the central role of the stress-activated MAPKs as effectors of TNF led to an examination of the contribution of these kinases to the negative regulation of insulin signaling (23, 111), with the demonstration that active JNK associates with and phosphorylates IRS1 in cells at several sites including…”
BackgroundInsulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
“Although inhibitory IRS-1 serine phosphorylation occurs at many different sites (BouraHalfon and Zick 2009), the best studied of these modifications occurs at Ser-307 (Aguirre et al. 2002).”
BackgroundInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Lipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
“When IRS1 is alternatively phosphorylated on serine 307, its downstream signaling ability is diminished [ 9 ].”
BackgroundCopps, K. D., & White, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2644-8 · Cited by 1,017
“In cultured cells that produce very little IRS2, insulin stimulates S307 phosphorylation via a PI3K pathway requiring the IRS1 YXXM motifs [39, 40].”
BackgroundSelf-citationEndoplasmic Reticulum Stress Signaling in Disease
Marciniak, S. J., & Ron, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00015.2006 · Cited by 945
“Consistent with this hypothesis, IRE1 / cells fail to active JNK or phosphorylate IRS-1 during ER stress unlike wild-type controls.”
BackgroundInfluentialInsulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929
“If IRSs are phosphorylated at some sites, such as serine 307, by some kinases, such as IKKβ/NF‐κB and c‐Jun N‐terminal kinase (JNK), its signaling activity is reduced (Aguirre et al., 2002).”
BackgroundPetersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
“Plasma concentrations of tumor necrosis factor- also decreased by 10% in these patients after weight loss and may also have played a minor contributing role in this process given its known ability to activate JNK1, which in turn will result in increased IRS-1 Ser(307) phosphorylation (33).”
BackgroundPositive and negative regulation of insulin signaling through IRS-1 phosphorylation
Gual, P., Le Marchand-Brustel, Y., & Tanti, J.-F. (2005) · Biochimie · doi:10.1016/j.biochi.2004.10.019 · Cited by 912
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883
DeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
“Increased IRS-1 serine phosphorylation, induced by metabolic/inflammatory abnormalities present in the diabetic state (reviewed by Draznin [114]), further impairs insulin signalling through the PI-3 kinase pathway [115, 116].”
BackgroundMorino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853
Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., van-Hylckama Vlieg, J. E. T., Strissel, K., Zhao, L., Obin, M., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2014.99 · Cited by 836
“…adipose tissue and the formation of CLS. Macrophage infiltration is an underlying cause of chronic adipose inflammation, insulin resistance and other obesity complications (Kanety et al., 1995; Aguirre et al., 2002; Weisberg et al., 2003; Xu et al., 2003; Strissel et al., 2007; Cani et al., 2008).”
BackgroundBomfim, T. R., Forny-Germano, L., Sathler, L. B., Brito-Moreira, J., Houzel, J.-C., Decker, H., Silverman, M. A., Kazi, H., Melo, H. M., McClean, P. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57256 · Cited by 832
“A recent study demonstrated that IRS-1pSer307 in mice is a positive regulatory site that sustains peripheral insulin signaling and moderates the severity of insulin resistance (65), in contrast to results obtained in previous cell-based experiments (26, 66, 67).”
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
“P A A uthor M anuscript binding domains (PTB) of IRS-1, Shc, and STAT5 (110, 246, 321, 573) (Fig.”
InfluentialTsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826
“has become a molecular indicator of insulin resistance (3,4,43,44).”
BackgroundInfluentialRetractedMorino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811
“Evidence in support of this hypothesis stems from in vitro studies demonstrating that mutating IRS-1 Ser307 to Ala307 abrogates TNF-1 α –induced insulin resistance in 32D IR cells (21).”
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Barbour, L. A., McCurdy, C. E., Hernandez, T. L., Kirwan, J. P., Catalano, P. M., & Friedman, J. E. (2007) · Diabetes Care · doi:10.2337/dc07-s202 · Cited by 811
Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex
Gao, Z., Hwang, D., Bataille, F., Lefevre, M., York, D., Quon, M. J., & Ye, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209459200 · Cited by 778
Insulin signaling in health and disease
White, M. F. (2003) · Science · doi:10.1126/science.1092952 · Cited by 733
Self-citationDing, S., Chi, M. M., Scull, B. P., Rigby, R., Schwerbrock, N. M. J., Magness, S., Jobin, C., & Lund, P. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012191 · Cited by 713
“Numerous studies have demonstrated that TNF-a limits insulin receptor signaling and promotes insulin resistance [15,23].”
BackgroundAdipocytokines in Obesity and Metabolic Disease
Cao, H. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0339 · Cited by 705
“JNK1 can directly inhibit insulin signaling by phosphorylating insulin receptor substrate 1 (IRS1) on serine residues (Aguirre et al. 2002) and can also potentiate fatty acid- induced cytokine production (Nguyen et al. 2005).”
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690
“Activation of JNK exhibit insulin resistance via phosphorylation of IRS-1 at serine site [Aguirre et al., 2000, 2002; Ozcan et al., 2004] which indicate that JNK plays a key role in the development of insulin resistance by inducing the production of TNF-a in liver, adipocytes, and peripheral…”
BackgroundUeki, K., Kondo, T., & Kahn, C. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5434-5446.2004 · Cited by 686
“TNF- stimulation increases serine phosphorylation of insulin receptor substrate 1 (IRS-1), decreasing its tyrosine phosphorylation by the insulin receptor (IR) kinase (2, 19).”
BackgroundNewsholme, P., Haber, E. P., Hirabara, S. M., Rebelato, E. L. O., Procopio, J., Morgan, D., Oliveira‐Emilio, H. C., Carpinelli, A. R., & Curi, R. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.135871 · Cited by 684
“It has been reported that serine phosphorylation of IRS-1 inhibits insulin-stimulated tyrosine phosphorylation of IRS-1, leading to an increase in insulin resistance (Aguirre et al. 2000, 2002).”
BackgroundSebastián, D., Hernández-Alvarez, M. I., Segalés, J., Sorianello, E., Muñoz, J. P., Sala, D., Waget, A., Liesa, M., Paz, J. C., Gopalacharyulu, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108220109 · Cited by 673
Alternative macrophage activation and metabolism
Odegaard, J. I., & Chawla, A. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130138 · Cited by 640
“Indeed, both JNK1 and inhibitor of NF-κB–kinase β (IKKβ, an NF-κB-activating kinase) directly phosphorylate serine residues on insulin receptor substrate 1, the major downstream effector of the insulin receptor, in response to TNFα stimulation (Figure 2) (38, 40, 41).”
Plomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627
“Phosphorylation of IRS-1 at Ser 307 (site 312 in human IRS-1) is critical for the inhibitory effect of TNF- , which appears to be mediated by an association of activated JNK with IRS-1 and the insulin receptor, thereby providing a mechanism to partly explain the development of insulin resistance in response to excessi…”
BackgroundSenn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620
Wang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006) · Endocrinology · doi:10.1210/en.2006-0251 · Cited by 600
“This change in serine phosphorylation has been linked to decreased insulin responses because of its interference with insulin receptor signaling (25, 26).”
BackgroundPhosphorylation of IRS proteins, insulin action, and insulin resistance
Boura-Halfon, S., & Zick, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90437.2008 · Cited by 598
The Molecular Basis for Oxidative Stress-Induced Insulin Resistance
Evans, J. L., Maddux, B. A., & Goldfine, I. D. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1040 · Cited by 587
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
“Serine phosphorylation of IRS1, known to attenuate insulin signalling by inhibiting tyrosine phosphorylation (Aguirre et al .”
BackgroundKhamzina, L., Veilleux, A., Bergeron, S., & Marette, A. (2005) · Endocrinology · doi:10.1210/en.2004-0921 · Cited by 562
The metabolic footprint of aging in mice
Houtkooper, R. H., Argmann, C., Houten, S. M., Cantó, C., Jeninga, E. H., Andreux, P. A., Thomas, C., Doenlen, R., Schoonjans, K., & Auwerx, J. (2011) · Scientific Reports · doi:10.1038/srep00134 · Cited by 528
“IRS-1 serine phosphorylation impedes its proper association with the insulin receptor and, therefore, the ability of insulin to promote IRS-1 tyrosine phosphorylation and activate Akt and PI3-kinase and its downstream pathway”
BackgroundMa, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1071-09.2009 · Cited by 536
“…With insulin resistance in diabetics and models, IRS-1 is phosphorylated by insulin-stimulated or stress-activated kinases, which uncouples IRS-1 (Aguirre et al., 2002) and triggers rapid IRS-1 degradation (Sun et al., 1999), yielding a deficient signal transduction response (Pederson et al.,…”
BackgroundInfluentialJNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships
Zeke, A., Misheva, M., Reményi, A., & Bogoyevitch, M. A. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00043-14 · Cited by 523
Solinas, G., Vilcu, C., Neels, J. G., Bandyopadhyay, G. K., Luo, J.-L., Naugler, W., Grivennikov, S., Wynshaw-Boris, A., Scadeng, M., Olefsky, J. M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.011 · Cited by 513
“To test whether deletion of Jnk1 in the hematopoietic compartment improves insulin signaling, we measured insulin-induced AKT phosphorylation in livers of WT+ Jnk1 À/À -BM and WT+WT-BM chimeras.”
BackgroundInfluentialFoundations of Immunometabolism and Implications for Metabolic Health and Disease
Hotamisligil, G. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.009 · Cited by 505
Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition
Hameed, I., Masoodi, S. R., Mir, S. A., Nabi, M., Ghazanfar, K., & Ganai, B. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.598 · Cited by 506
The Hyperglycemia-induced Inflammatory Response in Adipocytes
Lin, Y., Berg, A. H., Iyengar, P., Lam, T. K. T., Giacca, A., Combs, T. P., Rajala, M. W., Du, X., Rollman, B., Li, W., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411863200 · Cited by 497
Blázquez, E., Velázquez, E., Hurtado-Carneiro, V., & Ruiz-Albusac, J. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00161 · Cited by 491
“By contrast, the specific serine phosphorylation of the IRS-1/2 by the c-Jun N-terminal kinase (JNK1) and other protein kinases inhibits insulin-stimulated tyrosine phosphorylation, which correlates closely with insulin resistance (76).”
BackgroundChronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488
Glycogen synthase kinase 3: more than a namesake
Rayasam, G. V., Tulasi, V. K., Sodhi, R., Davis, J. A., & Ray, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00085.x · Cited by 483
“…phosphorylation of IRS1 on Ser residues has been reported (Eldar-Finkelman and Krebs, 1997), and overexpression of GSK3 leads to an increase in serine phosphorylation of IRS1 and decreased tyrosine phosphorylation of IRS1 and IR (Aguirre et al., 2002; Liberman and Eldar-Finkelman, 2005).”
BackgroundJing, E., Emanuelli, B., Hirschey, M. D., Boucher, J., Lee, K. Y., Lombard, D., Verdin, E. M., & Kahn, C. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111308108 · Cited by 469
“JNK has been shown to phosphorylate IRS-1 on serine 307 residue and to negatively regulate insulin signaling by reducing the IRS-1 tyrosine phosphorylation (24).”
BackgroundPathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Adipose Tissue, Inflammation and Atherosclerosis
Gustafson, B. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3939 · Cited by 469
An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450
Current views on type 2 diabetes
Lin, Y., & Sun, Z. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0260 · Cited by 457
“This phosphorylation reduces tyrosine phosphorylation of IRS1 in response to insulin (Hotamisligil et al. 1996, Paz et al. 1997, Aguirre et al. 2000, 2002).”
Backgroundc-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208359200 · Cited by 438
Self-citationInflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis
Gustafson, B., Hammarstedt, A., Andersson, C. X., & Smith, U. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147835 · Cited by 436
The major inflammatory mediator interleukin-6 and obesity
Eder, K., Baffy, N., Falus, A., & Fulop, A. K. (2009) · Inflammation Research · doi:10.1007/s00011-009-0060-4 · Cited by 433
“One possible mechanism is the serine phosphorylation of insulin receptor substrate 1 (IRS-1) by cytokine-activated kinases and the subsequent direct inhibitory effect on the insulin-signaling cascade [98].”
BackgroundJNK at the crossroad of obesity, insulin resistance, and cell stress response
Solinas, G., & Becattini, B. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2016.12.001 · Cited by 422
“The JNK phosphorylation site on IRS1 was mapped at serine-307, and it was shown that phosphorylation of this residue inhibits the interaction of IRS1 with the insulin receptor and tyrosine phosphorylation of IRS1 in response to insulin [14,15].”
BackgroundMetabolic Messengers: tumour necrosis factor
Sethi, J. K., & Hotamisligil, G. S. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00470-z · Cited by 419
SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes
Yoshizaki, T., Milne, J. C., Imamura, T., Schenk, S., Sonoda, N., Babendure, J. L., Lu, J.-C., Smith, J. J., Jirousek, M. R., & Olefsky, J. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00705-08 · Cited by 415
“IRS-1 serine (Ser)/threonine phosphorylation has been increasingly recognized as a negative regulator of IRS signaling (38), and Ser307 has been the most intensively studied and is a well-known target of JNK and inhibitor of B kinase (IKK ) (1, 8).”
BackgroundFrom JNK to Pay Dirt: Jun Kinases, their Biochemistry, Physiology and Clinical Importance
Karin, M., & Gallagher, E. (2005) · IUBMB Life · doi:10.1080/15216540500097111 · Cited by 412
“However, in response to obesity or inflammation, IRS1 becomes phosphorylated at S307, a modification that interferes with its recruitment to the IR and subsequent phosphorylation on tyrosine residues ( 109 ).”
BackgroundInsulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation
Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07084.2003 · Cited by 488
“Many proinflammatory signaling pathways inhibit the activity of Irs proteins by promoting Jnk-mediated serine phosphorylation or Socs-mediated ubiquitination (Aguirre et al., 2002; Rui et al., 2002).”
BackgroundSelf-citationThe role of MAPK signalling pathways in the response to endoplasmic reticulum stress
Darling, N. J., & Cook, S. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.009 · Cited by 399
“IRS1 undergoes Ser307 phosphorylation (equivalent to Ser312 on human IRS1) by JNK, which inhibits insulin-induced tyrosine phosphorylation of IRS1 and downstream signalling [177].”
BackgroundNishikawa, T., & Araki, E. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1458 · Cited by 391
“, Japan (No. 18590995 to T. N.), and by grants from Takeda Science Foundation (to T. N.).”
Proposed mechanisms for the induction of insulin resistance by oxidative stress
Bloch-Damti, A., & Bashan, N. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1553 · Cited by 388
Draznin, B. (2006) · Diabetes · doi:10.2337/db06-0391 · Cited by 388
The endoplasmic reticulum stress response in aging and age-related diseases
Brown, M. K., & Naidoo, N. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00263 · Cited by 376
“It is thought that JNK-mediated phosphorylation of serine residues in IRS1 inhibits the phosphorylation of IRS1 on tyrosine residues and leads to insulin resistance (Aguirre et al., 2002; Zhang and Kaufman, 2008).”
BackgroundRestraining PI3K: mTOR signalling goes back to the membrane
Harrington, L. S., Findlay, G. M., & Lamb, R. F. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.003 · Cited by 366
Bruce, C. R., Hoy, A. J., Turner, N., Watt, M. J., Allen, T. L., Carpenter, K., Cooney, G. J., Febbraio, M. A., & Kraegen, E. W. (2009) · Diabetes · doi:10.2337/db08-1078 · Cited by 363
“Given that phosphorylation of IRS-1 at Ser(307) can impair subsequent insulin-stimulated tyrosine phosphorylation (46), it is likely that the insulin-sensitizing effect of CPT1 overexpression is mediated by inhibiting the activation of serine kinases that interfere with insulin signaling.”
BackgroundProtein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101
Li, Y., Soos, T. J., Li, X., Wu, J., DeGennaro, M., Sun, X., Littman, D. R., Birnbaum, M. J., & Polakiewicz, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400186200 · Cited by 358
Obesity and Cancer: The Oil that Feeds the Flame
Font-Burgada, J., Sun, B., & Karin, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.015 · Cited by 356
“High saturated NEFA concentrations result in inhibitory phosphorylation of IRS-1 and -2 and suppression of insulin signaling (Aguirre et al., 2002; Solinas et al., 2006).”
BackgroundLiu, L., Zhang, Y., Chen, N., Shi, X., Tsang, B., & Yu, Y.-H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30565 · Cited by 356
Endoplasmic Reticulum Stress: Its Role in Disease and Novel Prospects for Therapy
Schönthal, A. H. (2012) · Scientifica · doi:10.6064/2012/857516 · Cited by 353
Discovery of Potent and Selective Covalent Inhibitors of JNK
Zhang, T., Inesta-Vaquera, F., Niepel, M., Zhang, J., Ficarro, S. B., Machleidt, T., Xie, T., Marto, J. A., Kim, N., Sim, T., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.11.010 · Cited by 349
“JNK1 phosphorylates IRS-1, a key molecule in the insulinsensing pathway that downregulates insulin signaling, and JNK1 knockout mice are resistant to diet-induced obesity (Aguirre et al., 2000, 2002; Hirosumi et al., 2002; Sabio and ier Ltd All rights reserved (A) Representative JNK inhibitors.”
BackgroundHotamisligil, G. S. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s73 · Cited by 352
“Serine phosphorylation of IRS-1 reduces both tyrosine phosphorylation of IRS-1 in response to insulin and the ability of IRS-1 to associate with insulin resistance and thereby suppresses downstream signaling and insulin action (30,34,35).”
JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347
Kapogiannis, D., Boxer, A., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U., Frassetto, L., Petersen, R. C., Miller, B. L., & Goetzl, E. J. (2015) · The FASEB Journal · doi:10.1096/fj.14-262048 · Cited by 345
TNF-α and cancer cachexia: Molecular insights and clinical implications
Patel, H. J., & Patel, B. M. (2017) · Life Sciences · doi:10.1016/j.lfs.2016.11.033 · Cited by 342
Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise
Corcoran, M. P., Lamon-Fava, S., & Fielding, R. A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.662 · Cited by 341
“Lipid-induced stimuli that lead to c-JUN NH2-terminal kinase (JNK) activation, such as the n–6 fatty acid linoleate (195), seem to inhibit IRS-1 function though serine(307) phosphorylation, thereby interrupting the IRS–insulin receptor interaction (196) or promoting IRS protein degradation (197).”
BackgroundAytug, S., Reich, D., Sapiro, L. E., Bernstein, D., & Begum, N. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.012 · Cited by 340
From excess adiposity to insulin resistance: The role of free fatty acids
Capurso, C., & Capurso, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.003 · Cited by 337
“The serine phosphorylation is responsible for IRS-1 blocking and the occurrence of insulin resistance through interruption of IR/ IRS interaction (Aguirre et al., 2002) and promotion of IRS-1 protein degradation (Greene et al.”
BackgroundGao, Z., Zhang, X., Zuberi, A., Hwang, D., Quon, M. J., Lefevre, M., & Ye, J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0383 · Cited by 335
“Ser307 of IRS-1 can be phosphorylated by either IKK or JNK (10, 12).”
BackgroundRANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
Bonnet, N., Bourgoin, L., Biver, E., Douni, E., & Ferrari, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125915 · Cited by 314
“In fat, TNF-α–induced inflammation was previously shown to attenuate IRS1 ability to transduce insulin signals, by the activation of IkB kinase β/NF-κb pathway (20, 32).”
High uric acid directly inhibits insulin signalling and induces insulin resistance
Zhu, Y., Hu, Y., Huang, T., Zhang, Y., Li, Z., Luo, C., Luo, Y., Yuan, H., Hisatome, I., Yamamoto, T., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.080 · Cited by 305
Bouzakri, K., Roques, M., Gual, P., Espinosa, S., Guebre-Egziabher, F., Riou, J.-P., Laville, M., Le Marchand-Brustel, Y., Tanti, J.-F., & Vidal, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1319 · Cited by 305
“Exposure of cultured cells to different factors, such as okadaic acid, tumor necrosis factor- , or insulin, increases serine phosphorylation of IRS-1 and promotes insulin resistance (14,31,32).”
BackgroundAkt and foxo Dysregulation Contribute to Infection-Induced Wasting in Drosophila
Dionne, M. S., Pham, L. N., Shirasu-Hiza, M., & Schneider, D. S. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.052 · Cited by 298
Gallagher, I. J., Scheele, C., Keller, P., Nielsen, A. R., Remenyi, J., Fischer, C. P., Roder, K., Babraj, J., Wahlestedt, C., Hutvagner, G., et al. (2010) · Genome Medicine · doi:10.1186/gm130 · Cited by 297
“The highest ranked signaling pathway, transforming growth factor-β signaling, is extensively implicated in all aspects of skeletal muscle function [61], while at an individual gene level, the directional changes in ERK1/2 and MEK1/2 are consistent with the emerging mechanism through which saturated fatty acids induce…”
BackgroundThe Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming
Bronson, S. L., & Bale, T. L. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.231 · Cited by 287
Molecular mechanisms of insulin resistance in type 2 diabetes mellitus
Saini, V. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i3.68 · Cited by 288
PPARs, Obesity, and Inflammation
Stienstra, R., Duval, C., Müller, M., & Kersten, S. (2007) · PPAR Research · doi:10.1155/2007/95974 · Cited by 287
“Copyright © 2007 Rinke Stienstra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
MethodStyskal, J., Van Remmen, H., Richardson, A., & Salmon, A. B. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.441 · Cited by 287
“Activation of JNK1 has been shown to directly phosporylate IRS-1 at inhibitory sites that prevent recruitment of this protein to the activated insulin receptor [104,105].”
BackgroundSomatotropic Signaling: Trade-Offs Between Growth, Reproductive Development, and Longevity
Bartke, A., Sun, L. Y., & Longo, V. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2012 · Cited by 287
Skeletal muscle insulin resistance: role of mitochondria and other ROS sources
Di Meo, S., Iossa, S., & Venditti, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0598 · Cited by 282
Solinas, G., Naugler, W., Galimi, F., Lee, M.-S., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607626103 · Cited by 284
Saturated Fatty Acids Induce c-Src Clustering within Membrane Subdomains, Leading to JNK Activation
Holzer, R. G., Park, E.-J., Li, N., Tran, H., Chen, M., Choi, C., Solinas, G., & Karin, M. (2011) · Cell · doi:10.1016/j.cell.2011.08.034 · Cited by 284
“For instance, JNKs phosphorylate insulin receptor substrates (IRS) 1 and 2 at serine (Ser) or threonine (Thr) residues and thereby attenuate their insulin-induced tyrosine (Tyr) phosphorylation, resulting in downmodulation of insulin action and diminished AKT activation (Aguirre et al., 2002; Solinas et al., 2006).”
Pirola, L., Johnston, A. M., & Van Obberghen, E. (2004) · Diabetologia · doi:10.1007/s00125-003-1313-3 · Cited by 283
“S307 is located in the IRS-1 PTB domain, and its phosphorylation is thought to hinder the PTB binding to the activated receptor [52].”
Background
Metadata
- Authors
- Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- ORCID
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 2
- Pages
- 1531-1537
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1972590376
- Cited by
- 1,010
- References
- 55
- Citations by year
- 2026: 27 · 2025: 24 · 2024: 26 · 2023: 25 · 2022: 27 · 2021: 35 · 2020: 30 · 2019: 43 · 2018: 41 · 2017: 33 · 2016: 40 · 2015: 36 · 2014: 57 · 2013: 45 · 2012: 58
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6852 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- IRS-1, insulin resistance, insulin signaling, phosphotyrosine binding domain, insulin receptor, JNK1, MAPK signaling, phosphatidylinositol 3-kinase, protein-protein interaction inhibition
- MeSH terms
- Animals, Anisomycin, Anti-Bacterial Agents, Cell Line, Humans, Insulin, Phosphoproteins, Phosphorylation, Receptor, Insulin, Recombinant Fusion Proteins, Tumor Necrosis Factor-alpha, Signal Transduction, Phosphatidylinositol 3-Kinases, Two-Hybrid System Techniques, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 8, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.